4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FDMT 4D Molecular Therapeutics

盘前交易 11-14 06:16:48 EST

7.71

-0.16

-2.03%

最高8.02	最低7.68	成交量53.45万
今开7.98	昨收7.87	日振幅4.26%
总市值4.01亿	流通市值2.04亿	总股本5,197万
成交额415.85万	换手率2.02%	流通股本2,640万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FDMT","market":"US","secType":"STK","nameCN":"4D Molecular Therapeutics","latestPrice":7.71,"timestamp":1731531600000,"preClose":7.87,"halted":0,"volume":534505,"delay":0,"floatShares":26397631,"shares":51969590,"eps":-2.3219,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.16,"latestTime":"11-14 06:16:48 EST","open":7.98,"high":8.015,"low":7.68,"amount":4158520.8978235,"amplitude":0.042567,"askPrice":8.6,"askSize":100,"bidPrice":5.55,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-2.3219,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731594600000},"adr":0,"listingDate":1607662800000,"adjPreClose":7.71,"postHourTrading":{"tag":"盘后","latestPrice":7.71,"preClose":7.71,"latestTime":"19:15 EST","volume":11522,"amount":88838.49,"timestamp":1731543303710},"volumeRatio":0.6999971451932651,"impliedVol":0.74,"impliedVolPercentile":0.3506},"requestUrl":"/m/hq/s/FDMT/tweets","defaultTab":"tweets","newsList":[{"id":"2478848784","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478848784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478848784?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:12","pubTimestamp":1730124762,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时12分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速拉升5.03%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Monte Rosa Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Tc Biopharm  Plc、Genprex, Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为619.58%、52.15%、51.74%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.，振幅分别为87.13%、84.14%、46.83%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028221242971a2ab3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028221242971a2ab3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2473488549","title":"4D Molecular Therapeutics, Inc.盘中异动 临近午盘急速下跌5.01%报9.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473488549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473488549?lang=zh_cn&edition=full","pubTime":"2024-10-07 23:54","pubTimestamp":1728316444,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日23时54分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速下跌5.01%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Scholar Rock Holding Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Aditxt, Inc.、Tc Biopharm  Plc、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1294.48%、57.64%、55.11%，振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为99.06%、39.46%、36.71%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007235405ab681eed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007235405ab681eed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FDMT","LENZ"],"gpt_icon":0},{"id":"2473699347","title":"4D Molecular Therapeutics, Inc.盘中异动 急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473699347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473699347?lang=zh_cn&edition=full","pubTime":"2024-10-05 02:13","pubTimestamp":1728065618,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日02时13分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅下挫5.03%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Seelos Therapeutics, Inc.较为活跃，换手率分别为17335.36%、74.74%、67.12%，振幅较大的相关个股有Aditxt, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为69.59%、58.64%、56.26%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100502133998e3aa62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100502133998e3aa62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2468462034","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468462034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468462034?lang=zh_cn&edition=full","pubTime":"2024-09-20 23:13","pubTimestamp":1726845199,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日23时13分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅跳水5.04%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.59%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202313199719c097&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202313199719c097&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2468357743","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘急速下跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468357743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468357743?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:34","pubTimestamp":1726752870,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时34分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速下挫5.59%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为1068.11%、380.50%、73.59%，振幅较大的相关个股有Exicure, Inc.、Portage Biotech Inc.、Transcode Therapeutics, Inc.，振幅分别为54.59%、18.67%、15.60%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091921343098e38169&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091921343098e38169&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2468054956","title":"美国研究综述-阿蒂拉制药公司、劳氏公司、宝洁公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2468054956","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468054956?lang=zh_cn&edition=full","pubTime":"2024-09-19 15:26","pubTimestamp":1726730808,"startTime":"0","endTime":"0","summary":"    路透9月19日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Athira 制药公司、劳氏公司和宝洁公司。要闻              * Athira pharma Inc   ：瑞穗将其评级从 \"跑赢大盘 \"下调至 \"中性\"。* Lowe's Companies Inc   ：TD Cowen将目标价从240美元上调至265美元             * 宝洁  ：摩根大通将目标价从179美元上调至186美元             * SS&C Technologies Holdings Inc   ：加拿大皇家银行将目标价从75美元上调至86美元 以下是路透周四报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","DRVN","LU0320765992.SGD","SGXZ23171101.USD","LU0266013472.USD","FDMT","RYAM","GIS","LOW","IE00BD4GTT62.SGD","ATHA","PGNY","LU1989763427.SGD","HALO","LU0320765489.SGD","BK4590","IE00B2PGVK34.USD","PG","BK4100","LU0477156953.USD","LU2106854487.HKD","NEP","FIVE","LU0130518102.USD","SG9999014575.USD","LU0109394709.USD","HQY","LU2242652126.USD","BK4566","KMX","LU0124676726.USD","LU1974910355.USD","SSNC","CHTR","LU1621767810.EUR","FTAI","BK4154","LU1621767737.EUR","LU0889566641.SGD","IE00BMG7P819.SGD","LU0096364046.USD","NEE","BK4527","BK4512","LU2237957811.SGD","GTY","ABT"],"gpt_icon":1},{"id":"2462992881","title":"4D Molecular Therapeutics, Inc.盘中异动 急速拉升5.28%报15.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462992881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462992881?lang=zh_cn&edition=full","pubTime":"2024-08-27 03:10","pubTimestamp":1724699428,"startTime":"0","endTime":"0","summary":"北京时间2024年08月27日03时10分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速拉升5.28%。截至发稿，该股报15.75美元/股，成交量19.2729万股，换手率0.37%，振幅4.41%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408270310289719a0d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408270310289719a0d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FDMT"],"gpt_icon":0},{"id":"2460241118","title":"4D Molecular Therapeutics, Inc.2024财年第二财季实现净利润-34.95百万美元，同比减少17.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460241118","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460241118?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824038,"startTime":"0","endTime":"0","summary":"8月17日，4D Molecular Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-34.95百万美元，同比减少17.99%；其中营业收入为5000.00美元，同比减少97.91%，每股基本收益为-0.63美元。从资产负债表来看，4D Molecular Therapeutics, Inc.总负债31.78百万美元，其中短期债务3.20百万美元，资产负债比为0.20，流动比率为0.29。机构评级：截至2024年8月17日，当前有10家机构对4D Molecular Therapeutics, Inc.目标价做出预测，其中目标均价为50.30美元，其中最低目标价为36.00美元，最高目标价为82.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006159f31b167&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006159f31b167&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT"],"gpt_icon":0},{"id":"2459420487","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘大幅拉升5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459420487","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459420487?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:30","pubTimestamp":1723728638,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时30分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速上涨5.27%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Cingulate Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Nutriband Inc C/Wts 涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为2126.22%、1426.01%、328.94%，振幅较大的相关个股有Celcuity Inc.、Sol-Gel Technologies Ltd.、Os Therapies Incorporated，振幅分别为9.31%、4.45%、3.48%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081521303997198cec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081521303997198cec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FDMT"],"gpt_icon":0},{"id":"2457477304","title":"4D Molecular Therapeutics, Inc.盘中异动 急速下挫8.61%报14.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457477304","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457477304?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:40","pubTimestamp":1722865249,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时40分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速下跌8.61%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.18%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Zevra Therapeutics, Inc.、Cervomed Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1091.82%、54.22%、14.18%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Alterity Therapeutics Limited、60 Degrees Pharmaceuticals, Inc.，振幅分别为21.59%、20.00%、17.81%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052140499f1074c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052140499f1074c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2457907722","title":"4D Molecular Therapeutics Inc   预计每股亏损70美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457907722","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457907722?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:59","pubTimestamp":1722862768,"startTime":"0","endTime":"0","summary":"   * 4D Molecular Therapeutics Inc    预计将在8月7日公布截至2024年6月30日的业绩报告时显示季度收入增长(预计)    * 根据LSEG的数据，9位分析师的平均预期显示，这家总部位于加利福尼亚州埃默里维尔的公司预计将实现448.6%的营收增长，从一年前的23.9万美元增至131.1万美元。* LSEG 分析师对 4D Molecular Therapeutics Inc 的平均预期是每股亏损 70 美分。* 华尔街对 4D Molecular Therapeutics Inc 的 12 个月目标价中位数为 43.00 美元，高于其最新收盘价 16.09 美元。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","FDMT"],"gpt_icon":0},{"id":"2456216674","title":"4D Molecular Therapeutics, Inc.盘中异动 下午盘大幅上涨5.07%报18.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456216674","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456216674?lang=zh_cn&edition=full","pubTime":"2024-08-01 02:49","pubTimestamp":1722451764,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日02时49分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅拉升5.07%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。其相关个股中，Molecular Partners Ag、Alpha Tau Medical Ltd C/Wts 、木薯科学涨幅较大，Cns Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为729.81%、169.08%、156.19%，振幅较大的相关个股有Molecular Partners Ag、Renovaro Inc.、Alpha Tau Medical Ltd C/Wts ，振幅分别为89.73%、79.10%、52.94%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080102492596822596&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080102492596822596&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2455511662","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.12%报17.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455511662","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455511662?lang=zh_cn&edition=full","pubTime":"2024-07-29 23:16","pubTimestamp":1722266164,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日23时16分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速下跌5.12%。截至发稿，该股报17.41美元/股，成交量7.4962万股，换手率0.14%，振幅4.98%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729231605aefbfcab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729231605aefbfcab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2454871709","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大涨5.18%报18.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454871709","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454871709?lang=zh_cn&edition=full","pubTime":"2024-07-25 21:56","pubTimestamp":1721915812,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日21时56分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速拉升5.18%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为1543.57%、371.50%、156.00%，振幅较大的相关个股有Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为114.90%、98.60%、50.00%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407252156529682051a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407252156529682051a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FDMT"],"gpt_icon":0},{"id":"2453795882","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453795882","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453795882?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:33","pubTimestamp":1721655236,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时33分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速拉升5.07%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Mei Pharma, Inc.、Enveric Biosciences, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为94.99%、78.40%、16.84%，振幅较大的相关个股有Exicure, Inc.、Aileron Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.，振幅分别为17.19%、14.23%、12.30%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722213356af9371c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722213356af9371c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FDMT"],"gpt_icon":0},{"id":"2452479222","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452479222","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452479222?lang=zh_cn&edition=full","pubTime":"2024-07-19 21:39","pubTimestamp":1721396395,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日21时39分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅下挫5.15%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virpax Pharmaceuticals, Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Silo Pharma, Inc.、Altamira Therapeutics Ltd.较为活跃，换手率分别为867.01%、232.97%、128.99%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.、Altamira Therapeutics Ltd.，振幅分别为48.37%、23.44%、23.13%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719213955af93307e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719213955af93307e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2452482546","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘大幅下跌5.00%报17.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452482546","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452482546?lang=zh_cn&edition=full","pubTime":"2024-07-18 21:31","pubTimestamp":1721309475,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日21时31分，4D Molecular Therapeutics, Inc.股票出现波动，股价大幅下挫5.00%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Onconetix, Inc.、Nkgen Biotech, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Onconetix, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为223.58%、123.31%、107.88%，振幅较大的相关个股有Onconetix, Inc.、亚狮康药业、Inventiva Sa，振幅分别为15.77%、11.27%、9.60%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182131159681e128&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182131159681e128&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2452385114","title":"纳斯达克生物科技指数收跌1%，成分股4D Molecular Therapeutics（FDMT）收跌31.96%表现最差，在美国视网膜专家协会（ASRA）年度科学会议上，该公司针对湿性年龄相关性黄斑变性的4D-150基因疗法的第二阶段临床试验数据偏正面；","url":"https://stock-news.laohu8.com/highlight/detail?id=2452385114","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452385114?lang=zh_cn&edition=full","pubTime":"2024-07-18 07:50","pubTimestamp":1721260241,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["QID","ARTL","LENZ","159837","PSQ","BK1147",".IXIC","BK4139","BK1141","159632","QLD","MNQmain","NQmain","BK1583","03086","NDX","BK1576","QQQ","TQQQ","SQQQ","03347","BK4007","FDMT"],"gpt_icon":0},{"id":"2452969511","title":"Chardan Capital：维持4D Molecular Therapeutics(FDMT.US)评级，由买入调整至买入评级, 目标价由38.","url":"https://stock-news.laohu8.com/highlight/detail?id=2452969511","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452969511?lang=zh_cn&edition=full","pubTime":"2024-07-18 03:02","pubTimestamp":1721242933,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FDMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2450535501","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘大幅上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450535501","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450535501?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:36","pubTimestamp":1720791417,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时36分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速上涨5.33%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。消息层面，截至21时36分，《富瑞集团维持4D Molecular Therapeutics买入评级，维持目标价58美元》资讯为影响4D Molecular Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213657af921ce1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213657af921ce1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.4dmoleculartherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0766},{"period":"1month","weight":-0.1462},{"period":"3month","weight":-0.4748},{"period":"6month","weight":-0.6957},{"period":"1year","weight":-0.3048},{"period":"ytd","weight":-0.6194}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.022},{"period":"3month","weight":0.0798},{"period":"6month","weight":0.1279},{"period":"1year","weight":0.3308},{"period":"ytd","weight":0.2564}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"4D Molecular Therapeutics, Inc.于2015年3月11日根据特拉华州法律成立。该公司是一家临床阶段基因治疗公司，开创了利用其靶向和进化的AAV载体开发候选产品的先河。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.114674},{"month":2,"riseRate":0.25,"avgChangeRate":0.09912},{"month":3,"riseRate":0.75,"avgChangeRate":0.041874},{"month":4,"riseRate":0.25,"avgChangeRate":-0.130346},{"month":5,"riseRate":0.5,"avgChangeRate":-0.163827},{"month":6,"riseRate":0,"avgChangeRate":-0.078465},{"month":7,"riseRate":0.75,"avgChangeRate":0.059232},{"month":8,"riseRate":0.25,"avgChangeRate":-0.049809},{"month":9,"riseRate":0.25,"avgChangeRate":-0.148039},{"month":10,"riseRate":0.25,"avgChangeRate":-0.11181},{"month":11,"riseRate":0.5,"avgChangeRate":0.473759},{"month":12,"riseRate":0.333333,"avgChangeRate":0.155196}],"exchange":"NASDAQ","name":"4D Molecular Therapeutics","nameEN":"4D Molecular Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"4D Molecular Therapeutics,FDMT,4D Molecular Therapeutics股票,4D Molecular Therapeutics股票老虎,4D Molecular Therapeutics股票老虎国际,4D Molecular Therapeutics行情,4D Molecular Therapeutics股票行情,4D Molecular Therapeutics股价,4D Molecular Therapeutics股市,4D Molecular Therapeutics股票价格,4D Molecular Therapeutics股票交易,4D Molecular Therapeutics股票购买,4D Molecular Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况